Skip to main content

FDA approves generic version of popular head lice medication

3/10/2009

NEWTOWN, Pa. The Food and Drug Administration has approved a generic topical medication for head lice.

Synerx Pharma has announced that the FDA approved its malathion lotion in the 0.5% strength. The lotion is a generic version of Taro Pharma’s Ovide lotion, used to treat patients with head lice and their eggs.

X
This ad will auto-close in 10 seconds